Patent · US Active

Compounds and methods for treating bacterial infections

US9839641B2 · kind B2 · utility

1Cited by

6References

28Claims

0Family size

Assignee

Entasis Therapeutics, Inc. · US

Inventors

Gregory Steven Basarab · Hockessin, US
Madhusudhan Reddy Gowravaram · Waltham, US
Sheila Hauck · Waltham, US
Fei Zhou · Shanghai, CN

Key dates

Filing date	Nov 16, 2016
Grant date	Dec 12, 2017
Priority date	—
Expiry date	Nov 16, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I), pharmaceutically acceptable salts thereof, and uses of the compounds of formula (I) for treating bacterial infections are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.